Gains May Be On The Menu For Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)
Currently, there are 361.49M common shares owned by the public and among those 179.87M shares have been available to trade. The company’s stock has a 5-day price change of 1.60% and -30.02% over the past three months. LXRX shares are trading 3.29% year to date (YTD), with the 12-month market performance down to -73.97% lower. […]
Lexicon Pharmaceuticals Inc (LXRX) Volatility Spurs A Quest For Clarity
Currently, there are 361.49M common shares owned by the public and among those 168.70M shares have been available to trade. The company’s stock has a 5-day price change of -8.56% and -46.54% over the past three months. LXRX shares are trading -5.89% year to date (YTD), with the 12-month market performance down to -67.67% lower. […]
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX): The Best-Of-Breed For Investing?
Currently, there are 361.49M common shares owned by the public and among those 168.72M shares have been available to trade. The company’s stock has a 5-day price change of 17.98% and -50.00% over the past three months. LXRX shares are trading 25.93% year to date (YTD), with the 12-month market performance down to -46.24% lower. […]
Is There More Upside Ahead For Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $0.84, with 10.16 million shares of worth about $8.53 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -57.79% during that period and on January 22, 2025 the price saw a […]
Lexicon Pharmaceuticals Inc (LXRX) Volatility Spurs A Quest For Clarity
Currently, there are 361.49M common shares owned by the public and among those 168.72M shares have been available to trade. The company’s stock has a 5-day price change of -10.50% and -56.70% over the past three months. LXRX shares are trading -4.43% year to date (YTD), with the 12-month market performance down to -52.31% lower. […]
Investors Should Take Note Of Lexicon Pharmaceuticals Inc (LXRX)
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $0.86, with 3.82 million shares of worth about $3.28 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -46.28% during that period and on January 08, 2025 the price saw a […]
Growing Through Challenges? – Lexicon Pharmaceuticals Inc (LXRX)
Currently, there are 244.93M common shares owned by the public and among those 238.68M shares have been available to trade. Insiders at the company have transacted a total of 56 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, […]
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX): The Best-Of-Breed For Investing?
Currently, there are 244.93M common shares owned by the public and among those 238.79M shares have been available to trade. Insiders at the company have transacted a total of 56 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, […]
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX): Analyst View Points To Future Growth
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $2.15, with 4.03 million shares of worth about $8.66 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 18.13% during that period and on Wednesday February 7 the price saw a […]
Are Analysts Expecting A Better 2020 For Lexicon Pharmaceuticals Inc (LXRX)?
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $1.87, with 4.94 million shares of worth about $9.23 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -3.61% during that period and on Wednesday, January 31 the price saw a […]
